5 results on '"Filippetti L"'
Search Results
2. Echocardiographic assessment of right ventricular function and right ventriculoarterial coupling in tricuspid regurgitation.
- Author
-
Trousselle L, Eggenspieler F, Huttin O, Pace N, Nazeyrollas P, Faroux L, Filippetti L, Fraix A, Carquin B, Metz D, and Selton-Suty C
- Subjects
- Humans, Male, Female, Aged, Middle Aged, Prognosis, Echocardiography, Doppler, Ventricular Dysfunction, Right physiopathology, Ventricular Dysfunction, Right diagnostic imaging, Ventricular Dysfunction, Right etiology, Reproducibility of Results, Area Under Curve, Risk Factors, Retrospective Studies, Atrial Function, Right, Aged, 80 and over, Tricuspid Valve Insufficiency physiopathology, Tricuspid Valve Insufficiency diagnostic imaging, Ventricular Function, Right, Predictive Value of Tests, Tricuspid Valve physiopathology, Tricuspid Valve diagnostic imaging, Severity of Illness Index
- Abstract
Echocardiographic evaluation of the cardiopulmonary unit is difficult in case of tricuspid regurgitation (TR) and combined echocardiographic parameters could be useful. This study aimed to assess the variation of simple and combined echocardiographic parameters analysing the cardiopulmonary unit according to the severity of TR. TR was graded according to Hahn's classification in 179 patients. Classical morphological, function and load parameters analysing right ventricle were assessed. Combined parameters of function and load; morphology and load; and morphology-load-function index were calculated. We used ROC curve analysis to analyze the diagnostic value of echocardiographic parameters to predict potential high or low surgical risk of mortality according to TRISCORE in 82 patients. Simple parameters were significatively different among groups with a nonlinear progression between the 5 levels of severity of TR. Combined parameters were also significatively different among groups. Among them, myomechanical index (MMI = RV-RA mean pressure gradient x RVFWS/indexed RAED area × 10
-2 ) and morphology-load-function index (MLF = RVED length/area x TR TVI x RVFWS) had a linear progression between the 5 groups and had the best predictive value for TRISCORE high and low risk. Combined parameters are relevant to evaluate cardiopulmonary unit in patients with various degrees of TR, especially when combining morphology, function, and load parameters, and are potentially interesting in their prognostic assessment, as shown by the good predictive value for TRISCORE risk., Competing Interests: Declarations Competing interests The authors declare no competing interests., (© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)- Published
- 2024
- Full Text
- View/download PDF
3. Factors Associated with Myocardial Uptake on Oncologic Somatostatin PET Investigations and Differentiation from Myocardial Uptake of Acute Myocarditis.
- Author
-
Larive T, Boursier C, Claudin M, Varlot J, Filippetti L, Huttin O, Roch V, Imbert L, Doyen M, Lambert A, Mandry D, Lamiral Z, Chevalier E, and Marie PY
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Acute Disease, Biological Transport, Diagnosis, Differential, Heart diagnostic imaging, Neoplasms diagnostic imaging, Neoplasms metabolism, Organometallic Compounds pharmacokinetics, Organometallic Compounds metabolism, Positron-Emission Tomography, Radiopharmaceuticals pharmacokinetics, Retrospective Studies, Myocarditis diagnostic imaging, Myocarditis metabolism, Myocardium metabolism, Octreotide analogs & derivatives, Octreotide metabolism, Octreotide pharmacokinetics, Somatostatin analogs & derivatives, Somatostatin metabolism
- Abstract
Myocardial somatostatin PET uptake is observed not only in most patients with acute myocarditis (AM) but also in some oncology patients referred for routine somatostatin PET. This raises concerns about the specificity of somatostatin PET for detecting myocarditis. The current study aims to identify factors associated with the detection of myocardial uptake on somatostatin PET scans recorded for oncology indications and differential PET criteria that characterize myocardial uptake in AM patients. Methods: We analyzed factors associated with the detection of myocardial [
68 Ga]Ga-DOTATOC uptake in 508 [68 Ga]Ga-DOTATOC PET scans from 178 patients, performed for confirmed or suspected oncologic disease (Onc-PET) and PET criteria that could differentiate myocardial [68 Ga]Ga-DOTATOC uptake in 31 patients with MRI-ascertained AM (AM-PET) from that in the Onc-PET group. Results: Significant myocardial uptake was detected in 137 (26.9%) Onc-PET scans and was independently associated with somatostatin analog treatment (exp(β), 0.805; 95% CI, 0.728-0.890; P < 0.001) and age (exp(β), 1.005; 95% CI, 1.001-1.009; P = 0.012). A comparable model was selected for predicting the myocardial-to-blood SUVmax ratio using somatostatin analog treatment ( P < 0.001) and history of coronary artery disease ( P = 0.022). Myocardial uptake was detected in 12.9% (25/193) of Onc-PET scans from patients treated with somatostatin analogs but in 43.4% (59/136) of untreated patients over the median age of 64 y. Myocardial uptake was apparent in all 31 AM-PET scans, with volume and intensity of uptake dramatically higher than in the 137 Onc-PET scans showing myocardial uptake. A myocardial-to-blood SUVmax ratio threshold of 2.20 provided a sensitivity of 87% (27/31) and a specificity of 88% (44/50) for differentiating myocardial uptake between the AM-PET group and an Onc-PET group restricted to patients with clinical characteristics comparable to those of patients in the AM-PET group (≤64 y of age, no coronary artery disease history, and no somatostatin agonists). A myocardial uptake volume threshold of 18 cm3 provided comparable diagnostic accuracy (sensitivity, 84% [26/31]; specificity, 94% [47/50]). Conclusion: Myocardial uptake was detected in 26.9% of somatostatin PET scans recorded for oncology indications. This rate was decreased by somatostatin analog treatments and increased in older individuals. However, somatostatin PET scans, analyzed with the quantitative criterion of uptake intensity or volume, are able to identify AM and to differentiate it from myocardial uptake of other origins., (© 2024 by the Society of Nuclear Medicine and Molecular Imaging.)- Published
- 2024
- Full Text
- View/download PDF
4. Advanced myocardial deformation echocardiography for evaluation of the athlete's heart: Functional and mechanistic analysis.
- Author
-
Colne E, Pace N, Fraix A, Gauthier F, Selton-Suty C, Chenuel B, Sadoul N, Girerd N, Lamiral Z, Felloni J, Djaballah K, Filippetti L, and Huttin O
- Subjects
- Humans, Male, Adult, Young Adult, Reproducibility of Results, Case-Control Studies, France, Ventricular Remodeling, Myocardial Contraction, Exercise Tolerance, Ventricular Function, Left, Predictive Value of Tests, Athletes, Cardiomegaly, Exercise-Induced, Stroke Volume, Ventricular Dysfunction, Left physiopathology, Ventricular Dysfunction, Left diagnostic imaging
- Abstract
Background: Assessment of the athlete's heart is challenging because of a phenotypic overlap between reactive physiological adaptation and pathological remodelling. The potential value of myocardial deformation remains controversial in identifying early cardiomyopathy., Aim: To identify the echocardiographic phenotype of athletes using advanced two-dimensional speckle tracking imaging, and to define predictive factors of subtle left ventricular systolic dysfunction., Methods: In total, 191 healthy male athletes who underwent a preparticipation medical evaluation at Nancy University Hospital between 2013 and 2020 were included. Clinical and echocardiographic data were compared with 161 healthy male subjects from the STANISLAS cohort. Borderline global longitudinal strain value was defined as<17.5%., Results: Athletes demonstrated lower left ventricular ejection fraction (57.9±5.3% vs. 62.6±6.4%; P<0.01) and lower global longitudinal strain (17.5±2.2% vs. 21.1±2.1%; P<0.01). No significant differences were found between athletes with and without a borderline global longitudinal strain value regarding clinical characteristics, structural echocardiographic features and exercise capacity. A borderline global longitudinal strain value was associated with a lower endocardial global longitudinal strain (18.8±1.2% vs. 22.7±1.9%; P=0.02), a lower epicardial global longitudinal strain (14.0±1.1% vs. 16.6±1.2%; P<0.01) and a higher endocardial/epicardial global longitudinal strain ratio (1.36±0.07 vs. 1.32±0.06; P<0.01). No significant difference was found regarding mechanical dispersion (P=0.46)., Conclusions: Borderline global longitudinal strain value in athletes does not appear to be related to structural remodelling, mechanical dispersion or exercise capacity. The athlete's heart is characterized by a specific myocardial deformation pattern with a more pronounced epicardial layer strain impairment., (Copyright © 2024 Elsevier Masson SAS. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
5. A new evidence-based echocardiographic approach to predict cardiovascular events and myocardial fibrosis in mitral valve prolapse: The STAMP algorithm.
- Author
-
Huttin O, Le Tourneau T, Filippetti L, Pace N, Sellal JM, Beaumont M, Mandry D, Marie PY, Selton-Suty C, and Girerd N
- Subjects
- Humans, Echocardiography, Mitral Valve diagnostic imaging, Mitral Valve surgery, Fibrosis, Mitral Valve Prolapse diagnostic imaging, Cardiomyopathies, Mitral Valve Insufficiency diagnostic imaging, Mitral Valve Insufficiency etiology
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.